Teladoc Health, Inc. (TDOC) Financial Statements (2023 and earlier)
Company Profile
| Business Address |
2 MANHATTANVILLE ROAD PURCHASE, NY 10577 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 8011 - Offices and Clinics of Doctors of Medicine (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in millions)Annual | Quarterly
| 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 918 | 900 | 884 | 839 | 896 | 826 | 786 | ||
| Cash and cash equivalents | 918 | 900 | 881 | 836 | 893 | 824 | 784 | ||
| Short-term investments | 3 | 3 | 3 | 3 | 3 | ||||
| Receivables | 236 | 226 | 227 | 214 | 169 | 178 | 179 | ||
| Inventory, net of allowances, customer advances and progress billings | 56 | 59 | 60 | 71 | 73 | 57 | 57 | ||
| Inventory | 56 | 59 | 60 | 71 | 73 | 57 | 57 | ||
| Prepaid expense | 63 | 59 | 49 | 51 | |||||
| Other current assets | 12 | 13 | 7 | 5 | |||||
| Other undisclosed current assets | 30 | 31 | 30 | 27 | 87 | 96 | 82 | ||
| Total current assets: | 1,315 | 1,288 | 1,257 | 1,208 | 1,225 | 1,157 | 1,105 | ||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 42 | 45 | 50 | 46 | 47 | 48 | 42 | ||
| Property, plant and equipment | 30 | 27 | 27 | 28 | 27 | 27 | 28 | ||
| Intangible assets, net (including goodwill) | 2,910 | 6,700 | 6,730 | 9,784 | 16,414 | 16,402 | 16,418 | ||
| Goodwill | 1,073 | 4,846 | 4,858 | 7,900 | 14,504 | 14,470 | 14,455 | ||
| Intangible assets, net (excluding goodwill) | 1,837 | 1,854 | 1,872 | 1,884 | 1,910 | 1,932 | 1,963 | ||
| Other noncurrent assets | 49 | 44 | 38 | 27 | 21 | 18 | 18 | ||
| Total noncurrent assets: | 3,030 | 6,816 | 6,846 | 9,884 | 16,509 | 16,495 | 16,506 | ||
| TOTAL ASSETS: | 4,345 | 8,104 | 8,103 | 11,092 | 17,735 | 17,653 | 17,611 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 196 | 279 | 231 | 122 | 166 | 138 | 126 | ||
| Interest and dividends payable | ✕ | 6 | 1 | 6 | 1 | 6 | 1 | ||
| Taxes payable | ✕ | 5 | 4 | 5 | 13 | 7 | 6 | ||
| Employee-related liabilities | ✕ | 63 | 52 | 46 | 92 | 76 | 60 | ||
| Accounts payable | 48 | 71 | 94 | 47 | 47 | 35 | 42 | ||
| Accrued liabilities | 148 | 135 | 80 | 17 | 13 | 15 | 17 | ||
| Deferred revenue | 90 | 90 | 86 | 84 | 76 | 73 | 69 | ||
| Estimated litigation liability | 3 | ||||||||
| Other liabilities | 50 | 33 | 34 | 30 | 30 | 30 | 20 | ||
| Other undisclosed current liabilities | 64 | 9 | 20 | 71 | 59 | 61 | 57 | ||
| Total current liabilities: | 400 | 411 | 371 | 307 | 331 | 302 | 276 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 1,535 | 1,576 | 1,578 | 1,573 | 1,267 | 1,254 | 1,238 | ||
| Long-term debt, excluding current maturities | 1,535 | 1,534 | 1,534 | 1,533 | 1,226 | 1,211 | 1,201 | ||
| Liabilities, other than long-term debt | 94 | 57 | 61 | 62 | 81 | 99 | 87 | ||
| Deferred revenue | 4 | 3 | 3 | 3 | 4 | 4 | 4 | ||
| Deferred income tax liabilities | 51 | 52 | 56 | 58 | 76 | 94 | 82 | ||
| Other liabilities | 2 | 2 | 2 | 1 | 1 | 1 | 1 | ||
| Operating lease, liability | 38 | 41 | 44 | 40 | 42 | 43 | 36 | ||
| Total noncurrent liabilities: | 1,630 | 1,632 | 1,639 | 1,635 | 1,349 | 1,353 | 1,324 | ||
| Total liabilities: | 2,030 | 2,043 | 2,010 | 1,941 | 1,680 | 1,655 | 1,600 | ||
| Equity | |||||||||
| Equity, attributable to parent | 2,308 | 6,053 | 6,085 | 9,143 | 16,046 | 15,988 | 16,001 | ||
| Common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Additional paid in capital | 17,359 | 17,300 | 17,239 | 17,177 | 17,473 | 17,399 | 17,315 | ||
| Accumulated other comprehensive income (loss) | (43) | (49) | (30) | (11) | (6) | (1) | 12 | ||
| Accumulated deficit | (15,008) | (11,198) | (11,125) | (8,023) | (1,421) | (1,410) | (1,326) | ||
| Total equity: | 2,308 | 6,053 | 6,085 | 9,143 | 16,046 | 15,988 | 16,001 | ||
| Other undisclosed liabilities and equity | 8 | 8 | 8 | 8 | 9 | 10 | 10 | ||
| TOTAL LIABILITIES AND EQUITY: | 4,345 | 8,104 | 8,103 | 11,092 | 17,735 | 17,653 | 17,611 | ||
Income Statement (P&L) ($ in millions) Annual | Quarterly
| 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 638 | 611 | 592 | 565 | 554 | 522 | 503 | |
| Cost of revenue | (196) | (186) | (182) | (187) | (175) | (169) | (160) | |
| Cost of goods and services sold | (186) | (182) | (187) | (175) | (169) | (160) | ||
| Gross profit: | 441 | 426 | 410 | 378 | 379 | 353 | 343 | |
| Operating expenses | (4,257) | (498) | (3,506) | (7,048) | (421) | (413) | (422) | |
| Operating loss: | (3,816) | (72) | (3,097) | (6,669) | (41) | (61) | (79) | |
| Nonoperating income (expense) (Other Nonoperating Income (Expense)) | 2 | (2) | (2) | 1 | (0) | (0) | 0 | |
| Interest and debt expense | (0) | (1) | (31) | |||||
| Loss from continuing operations before equity method investments, income taxes: | (3,814) | (73) | (3,098) | (6,669) | (42) | (62) | (110) | |
| Other undisclosed income (loss) from continuing operations before income taxes | 2 | (1) | (4) | (5) | (19) | (19) | (20) | |
| Loss from continuing operations before income taxes: | (3,812) | (75) | (3,103) | (6,674) | (61) | (81) | (131) | |
| Income tax expense (benefit) | 2 | 1 | 1 | (0) | 50 | (4) | (3) | |
| Loss from continuing operations: | (3,810) | (73) | (3,101) | (6,675) | (11) | (84) | (134) | |
| Loss before gain (loss) on sale of properties: | ✕ | (73) | (3,101) | (6,675) | (11) | (84) | (134) | |
| Net loss available to common stockholders, diluted: | (3,810) | (73) | (3,101) | (6,675) | (11) | (84) | (134) | |
Comprehensive Income ($ in millions)Annual | Quarterly
| 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (3,810) | (73) | (3,101) | (6,675) | (11) | (84) | (134) | |
| Other comprehensive income (loss) | 6 | (19) | (18) | (5) | (5) | (13) | 7 | |
| Comprehensive loss, net of tax, attributable to parent: | (3,804) | (93) | (3,120) | (6,680) | (16) | (98) | (127) | |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.